Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) is a blank check company formed to pursue a business combination in the health technology sector, with a focus on identifying targets in the digital health and medical technology industries. The SPAC completed its initial public offering in 2024 and is sponsored by Aimei Health Technology Sponsor LLC. The company filed an 8-K with the Securities and Exchange Commission on November 12, 2025, reflecting ongoing corporate activity as the vehicle continues its search and de-SPAC process. AFJK represents part of the continued wave of healthcare-focused blank check companies seeking to bring growth-stage companies to public markets via merger. Visit SpacDesk and sign up for full data, filings history, and real-time tracking on AFJK and hundreds of other active SPACs.